ARUP's Laboratory Test Directory

Dysautonomia, Familial (IKBKAP) 2 Mutations : 0051463
[ image for: Patient History For Molecular Genetic Testing]
Patient History For Molecular Genetic Testing
  


Mnemonic: IKBKAP

Ordering Recommendation: Diagnostic testing for familial dysautonomia. Carrier screening for familial dysautonomia.
Methodology: Polymerase Chain Reaction/ASPE Bead Array
Performed: Tue, Thu
Reported: 7-10 days
Specimen Required: Collect: Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).

Specimen Preparation: Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Reference Interval:
By report
Interpretive Data: Background information for Dysautonomia, Familial (IKBKAP) 2 Mutations:
Characteristics:
Debilitating disease of gastrointestinal dysfunction, vomiting and autonomic crises, recurrent pneumonia, altered sensitivity to pain and temperature, scoliosis, and cardiovascular instability. Other characteristics include infantile hypotonia, a broad-based ataxic gait that deteriorates, and decreased life expectancy.
Incidence:
1 in 3,600 Ashkenazi Jewish individuals, unknown in other ethnicities.
Inheritance:
Autosomal recessive.
Cause:
Deleterious IKBKAP gene mutations.
Mutations Tested:
R696P and IVS20(+6)T>C.
Clinical Sensitivity:
99 percent in Ashkenazi Jewish individuals, unknown in other ethnicities.
Methodology:
PCR and allele-specific primer extension by bead array with fluorescence detection.
Analytical Sensitivity and Specificity:
99 percent.
Limitations:
Mutations other than R696P and IVS20(+6)T>C will not be detected. Rare diagnostic errors can occur due to primer site mutations.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

See Compliance Statement C: www.aruplab.com/CS
CPT Code(s): 81260